Virus Clearance2026Friday, 07/24/2026Selective Risk Rating in Practice: Pinpointing CPPs and CMAs for an AEX Step
Virus Clearance2026Friday, 07/24/2026Beyond DoE: Mechanistic Modeling, Viral Surrogates and ICH Q5A(R2) for Next-Gen Virus Clearance
Virus Clearance2026Friday, 07/24/2026Smarter Virus Clearance: Replacing Worst-Case Testing With Data-Driven QbD
Continuous Bioprocessing2026Friday, 07/24/2026Perfusion-Mode Manufacturing for Complex Molecules: Continuous Bioprocessing Done Right
Process Development2026Friday, 07/24/2026A 42% Titer Uplift With Design of Experiments - Without Trading Away Quality
Quality by Design2026Friday, 07/24/2026Quality by Design from Concept to Clinic: Building Quality Into Biologics From Day One
Process Development2026Friday, 07/24/2026Managing the Unexpected: Rebuilding a Chromatography Step for a PPQ-Ready Process
Process Validation2026Friday, 07/24/2026PPQ Explained: Where Process Performance Qualification Fits in the FDA's Validation Lifecycle
